OCTAPHARMA AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07K PEPTIDES 28108
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
 
 
A23J PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS 416
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
 
 
B01D SEPARATION 3131
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
C12H PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION, AGEING OF ALCOHOLIC BEVERAGES OR REMOVAL OF ALCOHOL THEREFROM 17

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0189,494 PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIMar 20, 17Jul 06, 17[A61K]
2016/0340,410 A PROCESS FOR MANUFACTURING FACTOR VIII HAVING AN IMPROVED RATIO OF FVIII:C/FVIII:AGJan 20, 15Nov 24, 16[C07K]
2016/0152,661 PROCESS FOR ISOLATION AND PURIFICATION OF A TARGET PROTEIN FREE OF PRION PROTEIN (PRPSC)Dec 29, 15Jun 02, 16[C07K, B01D]
2015/0190,478 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIDec 11, 14Jul 09, 15[A61K]
2013/0079,498 PROCESS FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IXMar 30, 11Mar 28, 13[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901597 Method for inactivation/removal of coagulation factors by precipitationFeb 03, 12Feb 27, 18[A61K, C07K]
9796986 Serum-free stable transfection and production of recombinant human proteins in human cell linesDec 05, 16Oct 24, 17[C12N, C07K]
9512457 Serum-free stable transfection and production of recombinant human proteins in human cell linesFeb 01, 16Dec 06, 16[C12P, C12N, C07K]
9453045 Process for the purification of a growth factor proteinMar 30, 11Sep 27, 16[C07K, B01D]
9388402 Method for improved isolation of recombinantly produced proteinsMar 29, 06Jul 12, 16[C12P, C12N, C07K]
9371355 Process for production of fibrinogenSep 20, 11Jun 21, 16[C07K]
9296799 )Aug 25, 08Mar 29, 16[C07K]
9120873 Recombinantly produced human factor VIII and IXAug 21, 09Sep 01, 15[A61K, C07H, C12P, C12N, C07K]
9115381 Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIIIMay 14, 12Aug 25, 15[C12P, C12N, C07K]
8962813 Purification and use of a factor for supporting wound healingJan 25, 07Feb 24, 15[A61K, A23J, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0250,879 TEST FOR HEMOLYTIC POTENTIAL OF PHARMACEUTICAL PRODUCTS AND FORMULATIONS FOR RISK MINIMIZATIONAbandonedSep 26, 13Sep 10, 15[A61K, G01N, C07K]
2015/0031,621 METHOD FOR PURIFICATION OF COMPLEMENT FACTOR HAbandonedJul 09, 14Jan 29, 15[C07K]
2014/0051,839 Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation FactorsAbandonedNov 16, 11Feb 20, 14[C07K]
8518452 Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acidExpiredFeb 15, 08Aug 27, 13[A61K]
2013/0116,410 NEW STABILIZING AGENT FOR PHARMACEUTICAL PROTEINSAbandonedApr 20, 11May 09, 13[C07K]
2011/0189,752 COMPLEXAbandonedMay 06, 09Aug 04, 11[C08F, C12N, C07K]
2011/0178,019 NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIIIAbandonedSep 03, 09Jul 21, 11[A61K, A61P]
2011/0104,298 Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasmaAbandonedAug 24, 10May 05, 11[A61K]
2011/0008,459 Universally applicable blood plasmaAbandonedSep 17, 10Jan 13, 11[A61K, A61P]
2010/0330,568 ASSAY AND METHOD FOR THE ASSESSMENT OF RESPONDERS AND NON-RESPONDERS TO NK CELL MODULATION BY IMMUNOGLOBULIN THERAPYAbandonedJan 09, 09Dec 30, 10[C12Q]
2010/0145,021 PROCESS FOR ENHANCING PROTEIN RECOVERY YIELDSAbandonedJan 25, 08Jun 10, 10[C07K]
2009/0092,678 Universally applicable blood plasmaAbandonedAug 08, 08Apr 09, 09[A61K]
2008/0172,902 Lyophilisation targeting defined residual moisture by limited desorption energy levelsAbandonedJun 19, 07Jul 24, 08[F26B]
2007/0071,829 Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasmaAbandonedDec 20, 04Mar 29, 07[A61K, C12N]
2007/0014,806 Universally applicable blood plasmaAbandonedSep 21, 06Jan 18, 07[A61K, A01N]
2006/0234,907 Albumin solution and process for the production thereofAbandonedFeb 13, 04Oct 19, 06[C07K]
2006/0194,300 Process for preparing an alpha-1-antitrypsin solutionAbandonedAug 12, 04Aug 31, 06[C12N]
2005/0203,285 FiltrationAbandonedFeb 23, 05Sep 15, 05[A61K]
6893856 Process for preparing virus-inactivated factors 1X and X by membrane chromatographyExpiredMay 02, 02May 17, 05[C12N, C02F]
6777541 Protein purification IIExpiredJan 19, 01Aug 17, 04[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.